The frequency of and risk factors for the use of bisphosphonates in the adjuvant setting of primary breast cancer in Germany

Eva Maria Fick^*, Alexander Katalinic, Annika Waldmann

^*Corresponding author for this work

Institute of Social Medicine and Epidemiology

1 Citation (Scopus)

1 results

Finished
EBisMA: Einsatz von Bisphosphonaten in der adjuvanten Therapie des primären Mammakarzinoms
Katalinic, A. (Principal Investigator (PI)), Waldmann, A. (Speaker, Coordinator), Wolschon, E.-M. (Project Staff) & Fischer, D. (Project Staff)
01.03.12 → 31.12.13
Project: Endowments › Endowments